JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A5133 Irinotecan
2 Citation

Summary: Topoisomerase I inhibitor

insoluble in H2O; ≥11.4 mg/mL
A5424 Fludarabine
3 Citation

Summary: DNA synthsis inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
A5459 PHA-793887
1 Citation

Target: Cyclin-Dependent Kinases

Summary: Pan-Cdk inhibitor

insoluble in H2O; ≥18.05 mg/mL
A5801 BIX 02189

Target: MEK|ERK

Summary: Selective MEK5 inhibitor

≥22.05 mg/mL
A8311 Maraviroc
6 Citation

Target: CCR

Summary: Selective CCR5 antagonist,antiretroviral agent

≥25.7 mg/mL
A8427 Ethambutol dihydrochloride

Summary: Mycobacterial arabinosyltransferase inhibitor; for hyperuricemia and optic neuropathy models

≥12.65 mg/mL
A8632 (±)-Bay K 8644

Summary: L-type Ca2+-channel activator

≥36.2 mg/mL
B3033 Bay 11-7085
1 Citation

Summary: NK-κB activation inhibitor

≥12.45 mg/mL
B3058 CK-636
1 Citation

Target: Arp2/3 complex

Summary: Arp2/3 complex inhibitor

≥10.8 mg/mL
B3274 CCT007093

Summary: PPM1D inhibitor

insoluble in EtOH; insoluble in H2O; ≥3.4 mg/mL